Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 42 | 0 | 9 | 0 | €68.00 | €75.67 | 11.279% |
| AbbVie Inc. | 31 | 0 | 7 | 0 | €170.90 | €176.90 | 3.511% |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | €752.90 | €824.47 | 9.505% |
| Medpace Holdings Inc | 16 | 0 | 6 | 0 | €350.40 | €418.12 | 19.327% |
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €47.83 | €56.86 | 18.884% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | €26.67 | €54.98 | 106.153% |
| Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | €458.00 | €440.93 | -3.728% |
| Johnson & Johnson | 39 | 1 | 4 | 0 | €147.62 | €195.31 | 32.303% |
| Neurocrine Bioscience | 35 | 0 | 4 | 0 | €134.75 | €143.34 | 6.378% |
| Biogen Inc. | 52 | 1 | 4 | 0 | €198.10 | €292.88 | 47.843% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | €999.00 | €1,034.6 | 3.567% |
| United Therapeutics | 24 | 0 | 3 | 0 | €310.20 | €299.42 | -3.476% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.05 | - | - |
| Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | €2.27 | €8.55 | 275.792% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.74 | €17.56 | 540.730% |
| Pfizer Inc. | 29 | 4 | 2 | 0 | €28.18 | €41.29 | 46.539% |
| Exelixis Inc. | 20 | 0 | 2 | 0 | €20.79 | €26.01 | 25.091% |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 2 | 0 | €9.48 | €27.83 | 193.638% |
| Exact Sciences | 15 | 0 | 2 | 0 | €42.73 | €77.33 | 80.994% |
| Stoke Therapeutics Inc | 17 | 1 | 2 | 0 | €13.40 | €20.55 | 53.327% |
| Acadia Pharmaceuticals | 29 | 1 | 2 | 0 | €17.14 | €31.28 | 82.554% |
| Amgen Inc. | 25 | 0 | 2 | 0 | €309.35 | €304.65 | -1.520% |
| Twist Bioscience Corp | 11 | 0 | 2 | 0 | €55.50 | €53.41 | -3.774% |
| Alnylam Pharmace. | 44 | 0 | 2 | 0 | €219.00 | €253.95 | 15.961% |
| Abeona Therapeutics Inc. | 6 | 1 | 2 | 0 | €4.72 | €19.31 | 309.100% |